SERA PROGNOSTICS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SERA PROGNOSTICS, INC. (SERA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $823.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-12
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $823.00K, a 38.76% decline year-over-year.
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $835.00K, a 44.07% decline year-over-year.
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.25M, a 25.36% decline year-over-year.
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.34M, a 33.56% decline year-over-year.
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $5.11M, a 27.14% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $7.01M, a 33.00% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $5.27M, a 4.31% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $5.05M, a 61.50% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $823.00K 10-Q · filed 2026-08-12 | $1.66M derived: sum of 2 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $835.00K 10-Q · filed 2026-08-12 | |||
| 2025-12-31 | $5.11M 10-K · filed 2026-03-18 | |||
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-13 | $2.60M derived: sum of 2 quarters · filed 2026-08-12 | $4.09M derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-06-30 | $1.34M 10-Q · filed 2026-08-12 | $2.84M derived: sum of 2 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $1.49M 10-Q · filed 2026-08-12 | |||
| 2024-12-31 | $7.01M 10-K · filed 2026-03-18 | |||
| 2024-09-30 | $1.68M 10-Q · filed 2025-11-13 | $3.70M derived: sum of 2 quarters · filed 2025-11-13 | $5.40M derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | $2.02M 10-Q · filed 2025-11-13 | $3.72M derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | $1.69M 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $5.27M 10-K · filed 2025-03-19 | |||
| 2023-09-30 | $1.18M 10-Q · filed 2024-11-06 | $2.62M derived: sum of 2 quarters · filed 2024-11-06 | $3.93M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $1.44M 10-Q · filed 2024-11-06 | $2.74M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $1.30M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $5.05M 10-K · filed 2024-03-20 | |||
| 2022-09-30 | $1.28M 10-Q · filed 2023-11-08 | $2.49M derived: sum of 2 quarters · filed 2023-11-08 | $3.71M derived: sum of 3 quarters · filed 2023-11-08 | |
| 2022-06-30 | $1.21M 10-Q · filed 2023-11-08 | $2.44M derived: sum of 2 quarters · filed 2023-11-08 | ||
| 2022-03-31 | $1.22M 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $3.13M 10-K · filed 2023-03-22 | |||
| 2021-09-30 | $914.00K 10-Q · filed 2022-11-09 | $1.78M derived: sum of 2 quarters · filed 2022-11-09 | $2.02M derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $864.00K 10-Q · filed 2022-11-09 | $1.10M derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $239.00K 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $726.00K 10-K · filed 2022-03-29 | |||
| 2020-09-30 | $195.00K 10-Q · filed 2021-11-09 | $396.00K derived: sum of 2 quarters · filed 2021-11-09 | $531.00K derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $201.00K 10-Q · filed 2021-11-09 | $336.00K derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | $135.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |